Policy

Contraception in Perimenopause Policy

How contraceptive need is assessed in patients who may still conceive, what the service prescribes or arranges, how contraception fits alongside HRT and testosterone, and when contraception can safely be stopped

For Women's Health & Menopause ClinicRef BS-WOM-POL-006See a sample (PDF) →
£44.99
One-off purchase · no VAT · instant download
  • Instant download after checkout
  • Editable Microsoft Word (.docx)
  • Mapped to the CQC standards
  • Optional 3-monthly updates

What's inside

This policy is fully drafted and structured, ready to brand and complete for your service. It covers:

  • 1. Purpose
  • 2. Scope
  • 3. Policy statement
  • 4. Definitions
  • 5. The rule that applies to every consultation
  • 6. Assessing contraceptive need
  • 7. Methods within scope
  • 8. Contraception alongside HRT and testosterone
  • 9. Drug interactions
  • 10. Emergency contraception and sexual health
  • 11. When contraception can be stopped
  • 12. Roles and responsibilities
  • 13. Training and competence
  • 14. Records, monitoring and audit
  • 15. Related documents
  • 16. Version control and review
  • 17. Appendix A - Contraception Assessment Record
  • 18. Disclaimer

CQC fundamental standard

Regulation 9 (Person-centred care)
This document is written to evidence that standard. Health and Social Care Act 2008 (Regulated Activities) Regulations 2014.

Legislation & standards it maps to

  • National Institute for Health and Care Excellence (NICE) guideline NG23, Menopause: identification and management (as last updated).
  • College of Sexual and Reproductive Healthcare (CoSRH, formerly the Faculty of Sexual and Reproductive Healthcare), Contraception for Women Aged Over 40 Years (as amended).
  • CoSRH, UK Medical Eligibility Criteria for Contraceptive Use (UKMEC 2025).
  • CoSRH clinical guidelines and guidance: Intrauterine Contraception (as amended); Emergency Contraception (as amended); Progestogen-only Pills (as amended); Drug Interactions with Hormonal Contraception.
  • British Menopause Society (BMS) consensus statements and Tools for Clinicians, including Progestogens and endometrial protection, and Testosterone replacement in menopause.
  • General Medical Council (GMC), Good practice in proposing, prescribing, providing and managing medicines and devices, including the sections on remote prescribing and on medicines requiring additional safeguards.
  • GMC, Remote consultations guidance and decision flowchart.
  • Health and Social Care Act 2008 (Regulated Activities) Regulations 2014: Regulation 9 (Person-centred care), Regulation 10 (Dignity and respect), Regulation 11 (Need for consent), Regulation 12 (Safe care and treatment), Regulation 13 (Safeguarding service users from abuse and improper treatment), Regulation 17 (Good governance) and Regulation 20 (Duty of candour).
  • Human Medicines Regulations 2012.
  • Equality Act 2010.
  • UK General Data Protection Regulation and Data Protection Act 2018; Records Management Code of Practice (2023).
  • Care Quality Commission (CQC) assessment framework: the five key questions (safe, effective, caring, responsive and well-led) and the quality statements of the single assessment framework, and the sector-specific framework for primary care and community services when it replaces them.

Who it applies to

All clinical and administrative staff, including self-employed and locum clinicians

Glossary

Plain-English explanations of the technical terms and legislation used in this document.

Amenorrhoea
Having no periods.
BMI (body mass index)
A measure of weight relative to height, used in deciding whether some contraceptives are safe.
BMS (British Menopause Society)
The UK specialist society for menopause care, which publishes consensus statements and Tools for Clinicians.
BRCA1 and BRCA2
Genes which, when altered, greatly increase the risk of breast and ovarian cancer.
CHC (combined hormonal contraception)
The combined pill, patch or ring, containing an oestrogen and a progestogen.
CoSRH (College of Sexual and Reproductive Healthcare)
The UK professional body for sexual and reproductive healthcare, formerly the Faculty of Sexual and Reproductive Healthcare. It publishes national contraception guidelines.
CQC (Care Quality Commission)
The independent regulator of health and adult social care in England.
Cu-IUD (copper intrauterine device)
A non-hormonal device placed in the womb that prevents pregnancy; also the most effective emergency contraception.
DMPA (depot medroxyprogesterone acetate)
The progestogen-only contraceptive injection, given every 13 weeks.
Endometrial protection
Giving enough progestogen to stop oestrogen from causing overgrowth or cancer of the womb lining.
Enzyme inducer
A medicine or herbal product that speeds up how the liver breaks down some hormones, making some contraceptives less effective.
FSH (follicle-stimulating hormone)
A hormone that rises as the ovaries stop working; a blood test is sometimes used to help decide when contraception can stop.
GMC (General Medical Council)
The regulator of doctors in the UK.
GP (general practitioner)
The patient's registered family doctor.
GPhC (General Pharmaceutical Council)
The regulator of pharmacists and pharmacy technicians in Great Britain.
HRT (hormone replacement therapy)
Oestrogen, usually with a progestogen, used to relieve menopausal symptoms. It is not a contraceptive.
IU/L (international units per litre)
The unit used to report FSH blood test results.
LNG-IUS (levonorgestrel intrauterine system)
A hormone-releasing device placed in the womb. The 52 mg version provides contraception and can protect the womb lining during HRT. CoSRH now calls it an LNG-IUD (levonorgestrel intrauterine device).
NICE (National Institute for Health and Care Excellence)
The body that publishes national clinical guidelines for England, including NG23 on the menopause.
NMC (Nursing and Midwifery Council)
The regulator of nurses and midwives in the UK.
Off-label
Use of a licensed medicine or device in a way not covered by its licence, for example for longer than the licensed duration.
Perimenopause
The years around the menopause when periods become irregular, lasting until 12 months after the final period.
POI (premature ovarian insufficiency)
Loss of normal ovarian function before the age of 40. Pregnancy is still possible.
POP (progestogen-only pill)
A contraceptive pill containing only a progestogen, sometimes called the mini pill.
Progestogen
A hormone similar to progesterone, used in contraception and to protect the womb lining in HRT.
Reproductive coercion
Behaviour that controls a person's decisions about pregnancy or contraception, such as sabotaging contraception. It is a form of domestic abuse.
SOP (standard operating procedure)
A step-by-step document describing how a task is carried out.
STI (sexually transmitted infection)
An infection passed on through sexual contact.
UK (United Kingdom)
England, Scotland, Wales and Northern Ireland.
UK GDPR (UK General Data Protection Regulation)
The UK law, alongside the Data Protection Act 2018, governing how personal information is used and protected.
UKMEC (UK Medical Eligibility Criteria for Contraceptive Use)
The CoSRH classification (current edition UKMEC 2025) of how safe each contraceptive method is for people with particular medical conditions.
VTE (venous thromboembolism)
A blood clot in a vein, such as a deep vein thrombosis or a pulmonary embolism.
Care Quality Commission assessment framework
The CQC's framework of key questions and quality statements used to assess registered services.
Data Protection Act 2018
The UK law that sits alongside the UK GDPR on the use of personal data.
Duty of candour
The legal duty under Regulation 20 to be open and honest with a patient when a notifiable safety incident occurs.
Equality Act 2010
The law protecting people from discrimination on grounds including sex, gender reassignment, age and disability.
Health and Social Care Act 2008 (Regulated Activities) Regulations 2014
The regulations setting the fundamental standards that CQC-registered providers must meet.
Human Medicines Regulations 2012
The main UK law on the licensing, supply and prescribing of medicines.
Records Management Code of Practice (2023)
National guidance on how long health and care records are kept and how they are managed.
Ulipristal acetate and levonorgestrel
The two emergency contraceptive pills available in the UK.
Virilisation
Development of male characteristics, which testosterone can cause in a female fetus.

How it works

  1. Buy securely with Stripe - instant, no VAT, no account needed.
  2. Download your editable Word file from the link we email you straight away.
  3. Complete the placeholders for your service, then have it approved before use.
  4. Add the optional updates subscription and we keep it current as guidance changes.

Related documents

PolicyWomen's Health Scope of Service Policy£44.99
PolicyMenopause Assessment & Diagnosis Policy£44.99
PolicyHRT Prescribing Policy£44.99
PolicyTestosterone Prescribing in Women Policy£44.99

Need the whole set?

Buy the full Women's Health & Menopause Clinic pack and save versus buying documents individually.

View the Women's Health & Menopause Clinic pack →